Indeterminate Lesions of Eye clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma
open to eligible people ages 18 years and up
The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.